The U.S. healthcare system is currently navigating unprecedented challenges as the CDC faces a leadership crisis. This turmoil has intensified debates over Ivermectin access, its affordability, and its preventive medicine role. Americans are increasingly questioning institutional guidance while exploring preventive care options, highlighting the tension between public health directives and...